Trial Outcomes & Findings for Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy (NCT NCT01048125)
NCT ID: NCT01048125
Last Updated: 2016-11-23
Results Overview
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
2 participants
Primary outcome timeframe
2 years
Results posted on
2016-11-23
Participant Flow
2 participants were consented, but due to difficulty in recruitment and resource restraints the study did not progress as expected and was closed.
Participant milestones
| Measure |
Study Group
Subjects with documented stress cardiomyopathy who would serve as the study group. Sympathetic Nerve Activity; Mental StrCold Pressor Testess Test (Color Word Test); The Modified Oxford Technique for Baroreflex Sensitivity; Cold Pressor Test; Echocardiographic evaluation
|
Control
Control subjects will be age and sex matched otherwise healthy people with no prior cardiac disease or other severe medical conditions. Sympathetic Nerve Activity; Mental Stress Test (Color Word Test); The Modified Oxford Technique for Baroreflex Sensitivity; Cold Pressor Test; Echocardiographic evaluation
Sympathetic Nerve Activity: Resting Sympathetic Nerve Activity
Mental Stress Test (Color Word Test): A printed word will be shown to the subject, displayed in a color different from the color it actually names. The subject will be asked to say the color that the word is printed in as quickly as possible. For example if the word "green" is written in blue ink, they will say "blue." This mental stress procedure will be used to cause brief changes in heart rate and blood pressure.
The Modified Oxford Technique for Baroreflex Sensitivity: Sodium nitroprusside (100 µg) will be infused intravenously as a bolus, followed 60 seconds later by a bolus of phenylephrine hydrochloride
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
Baseline characteristics by cohort
| Measure |
Study Group
Subjects with documented stress cardiomyopathy who would serve as the study group. Sympathetic Nerve Activity; Mental StrCold Pressor Testess Test (Color Word Test); The Modified Oxford Technique for Baroreflex Sensitivity; Cold Pressor Test; Echocardiographic evaluation
|
Control
Control subjects will be age and sex matched otherwise healthy people with no prior cardiac disease or other severe medical conditions. Sympathetic Nerve Activity; Mental Stress Test (Color Word Test); The Modified Oxford Technique for Baroreflex Sensitivity; Cold Pressor Test; Echocardiographic evaluation
|
Total
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
—
|
—
|
0
n=27 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
—
|
—
|
0
n=27 Participants
|
|
Age, Categorical
>=65 years
|
—
|
—
|
0
n=27 Participants
|
|
Gender
Female
|
—
|
—
|
0
n=27 Participants
|
|
Gender
Male
|
—
|
—
|
0
n=27 Participants
|
|
Region of Enrollment
United States
|
—
|
—
|
0
n=27 Participants
|
PRIMARY outcome
Timeframe: 2 yearsPopulation: Due to difficulty in recruitment and resource restraints the study did not progress as expected and was closed.
Outcome measures
Outcome data not reported
Adverse Events
Study Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Control
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place